Allosteric inhibition of endothelin ETA receptors by 3,5-dibromosalicylic acid

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1461-1469

  Blandin, Virginie ^a   Vigne, Paul ^a   Breittmayer, Jean Philippe ^b   Frelin, Christian ^a  

^a CNRS   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBENZOIC ACID; 3,5 DIBROMO 4 HYDROXYBENZOIC ACID; 3,5 DIBROMOSALICYLIC ACID; 3,5 DIFLUOROBENZOIC ACID; 3,5 DIIODOSALICYLIC ACID; 3,5 DIISOPROPYLSALICYLIC ACID; 3,5 DINITROBENZOIC ACID; 3,5 DINITROSALICYLIC ACID; 4 HYDROXYBENZOIC ACID; 5 BROMO 2,4 DIHYDROXYBENZOIC ACID; ACETYLSALICYLIC ACID; BENZOIC ACID; BENZOIC ACID DERIVATIVE; BOSENTAN; CALCIUM; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HYDROXYTOLUIC ACID; MESALAZINE; NICOTINIC ACID; PICOLINIC ACID; SALICYLAMIDE; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; SALICYLIC ACID METHYL ESTER; SALIGENIN; SALSALATE; SULFOSALICYLIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOSTERISM; CALCIUM MOBILIZATION; CONTROLLED STUDY; DISSOCIATION; DRUG MECHANISM; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SHORT SURVEY;

EID: 0033675266     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1461     Document Type: Short Survey

References (33)

1. Cell stress and MAKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation
2. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye coupling
3. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-bensoylthiophenes
4. Pathophysiological role of endothelin by the first orally active endothelin receptor antagonist
5. Interaction of endothelin-1 with cloned bovine ETA receptors: Biochemical parameters and functional consequences
6. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods
7. Evidence for receptor bound endothelin in renal but not in cardiac tissues from normal rats
8. Why are circulating levels of endotbolin so low?
9. Et-1 and Et-3 actions mediated by cloned ETA endothelin receptors exhibit different sensitivities to BQ-123
10. The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes
11. Regulation of D2 dopamine receptors by amiloride and amiloride analogs
12. Detection, quantification, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interaction of strychnine and acetylcholine at muscarinic receptors
13. Regulation of ANP secretion by endothelin-1 in cultured atrial myocytes: Desensitization and receptor subtype
14. Agonist-induced increase in apparent β-adrenergie receptor size
15. Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta
16. Kinetics of the vasoconstrictor action of endothelins
17. Correlation between guanine nucleotide effect and reversible property of endothelin analogs
18. + exchange
19. Aspirin as an antiplatelet drug
20. Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA selective antagonists and endothelinB selective agonists
21. Activation of p38 mitogen activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor induced IkBα phosphorylation and degradation
22. Cell-type specific activation of c-Jun N-terminal kinases by salicylates
23. Sodium salicylate induces apoptosis via p38 mitogen activated protein kinase but inhibits tumor necrosis factor induced c-jun N-terminal kinase/stress-activated protein kinase activation
24. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms
25. Aspirin and sodium salicylate inhibit ETA receptors by an allosteric type of mechanism
26. Allosteric modulation of muscarinic acetylcholine receptors
27. Molecular mechanism of action of the vasoconstrictor peptide endothelin
28. Competitive and noncompetitive interactions of BQ-123 with endothelin ETA receptors
29. Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells
30. 125I]endothelin-1 binding data
31. Aminosalicylic acid inhibits IκB kinase α phosphorylation of IκBα in mouse intestinal epithelial cells
32. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
33. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β